Skip to main content

Abselion

The startup develops biosensor technologies that enable the analysis of proteins and small molecules in pharmaceutical research and manufacturing. Its diagnostic analyzers and kits facilitate rapid and sensitive biomolecular interaction assessments, providing near real-time medical diagnostics for researchers.

Traction –/10
Cambridge, United Kingdom · HQ
232K+ followers
  • Biotechnology
  • Healthcare Technology
  • Medical Devices
Updated 5 months ago

Funding

Raised to date

$12.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

2 founders

Oliver Hardick

CEO

Ruizhi Wang

CEO

Product

Features

  • The startup develops biosensor technologies that enable the analysis of proteins and small molecules in pharmaceutical research and manufacturing. Its diagnostic analyzers and kits facilitate rapid and sensitive biomolecular interaction assessments, providing near real-time medical diagnostics for researchers.
This profile is AI-generated and may contain inaccuracies.